Company News
BCMPA announces the death of Rodney Steel
BCMPA announces the death of Rodney Steel
It is with great regret that the BCMPA announces that Rodney Steel, former CEO of the BCMPA, has died following a short illness
Rob Orford OBE named new Chief Executive of Moondance Cancer Initiative
Rob Orford OBE named new Chief Executive of Moondance Cancer Initiative
Wales’ most senior healthcare scientist has taken on a new role to further improve cancer outcomes
Jean-Marc Huët to succeed Albert M. Baehny as Chair of Lonza
Jean-Marc Huët to succeed Albert M. Baehny as Chair of Lonza
The board look forward to welcoming Jean-Marc Huët into the position of Chairperson
BICO Group AB announces Catharina Nordlund as their new Global Head of HR
BICO Group AB announces Catharina Nordlund as their new Global Head of HR
Ms Nordlund will further strengthen the Executive Management and be responsible for shaping and executing BICO’s global HR strategy
Cellular Origins appoints Peter Crossley as Chief Operating Officer
Cellular Origins appoints Peter Crossley as Chief Operating Officer
Cellular origins, a TTP company, recently appointed Peter Crossley as the COO after 27 years of industry experience
Onyx Scientific targets stateside expansion with new appointment
Onyx Scientific targets stateside expansion with new appointment
Leading small molecule CDMO Onyx Scientific is set to expand its commercial operations in the United States with the appointment of Anthony Harbour as Business Development...
AES Clean Technology expands senior leadership team with key appointment
AES Clean Technology expands senior leadership team with key appointment
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO)
SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit
SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit
The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe
Nuclera announces the appointment of Jonathan Milner as Chairman of the Board
Nuclera announces the appointment of Jonathan Milner as Chairman of the Board
Nuclera, the pioneer in bringing rapid protein prototyping to the benchtop, is delighted to announce the appointment of Jonathan Milner as the Non-executive Chairman of the...
Corteria Pharmaceuticals appoints Mark Pruzanski as Chair of its Board of Directors
Corteria Pharmaceuticals appoints Mark Pruzanski as Chair of its Board of Directors
Corteria Pharmaceuticals, a biopharmaceutical company specialised in the development of transformative therapies for heart failure and obesity, announces the appointment of...
X‑Chem transitions executives into new roles, appoints new Chief Executive Officer
X‑Chem transitions executives into new roles, appoints new Chief Executive Officer
X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced executive management team changes aimed at expanding its position as a...
2cureX announces changes to the Board of Directors
2cureX announces changes to the Board of Directors
2cureX, a pioneer in the use of 3D tumoroids for predicting cancer treatment efficacy, is implementing significant changes in its governance resulting in four Board members...
Stuart Quin joins GHO Capital as Partner
Stuart Quin joins GHO Capital as Partner
Former CEO of Medica Group and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investments
SpliceBio appoints leading ophthalmology expert Aniz Girach as Chief Medical Officer
SpliceBio appoints leading ophthalmology expert Aniz Girach as Chief Medical Officer
Appointment further strengthens SpliceBio’s leadership team as it accelerates lead programme targeting Stargardt disease towards clinical development
Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing
Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing
Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions
Lucas Sauer-Jones appointed as Vice President & General Manager of Veranova’s New England sites
Lucas Sauer-Jones appointed as Vice President & General Manager of Veranova’s New England sites
Sauer-Jones will be responsible for US API maker Veranova’s sites in Devens and North Andover
Industry veteran Abbas Hussain appointed as Chair of Asceneuron
Industry veteran Abbas Hussain appointed as Chair of Asceneuron
This follows the appointment of Barbara Angehrn Pavik as Chief Executive Officer, signaling a concerted effort to propel the development of groundbreaking treatments aimed at...
OM Pharma appoints Roch Ogier as Chief Executive Officer
OM Pharma appoints Roch Ogier as Chief Executive Officer
OM Pharma, a global biopharmaceutical company headquartered in Switzerland, announced the appointment of Roch Ogier as Chief Executive Officer (CEO), effective January 1, 2024
Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board
Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board
The appointment supports ambitious commercialisation strategy for DNA synthesis platform, gSynth, and follows $10m Series A financing to scale operations
Astraveus appoints Dr Lars Henrik Peeck as Chief Business Development Officer
Astraveus appoints Dr Lars Henrik Peeck as Chief Business Development Officer
Appointment signifies a pivotal move for Astraveus as it expands its executive team to advance its groundbreaking cell and gene therapy (CGT) manufacturing solutions
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
Rentschler Biopharma SE, a leading contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including Advanced Therapy Medicinal Products (ATMPs),...
Santhera appoints Executive Committee members as it transitions into commercial stage
Santhera appoints Executive Committee members as it transitions into commercial stage
Santhera Pharmaceuticals (SIX: SANN) announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer (CCO) and of Marc Schrader to Chief Technology Officer...
Jose Ibietatorremendia to join Veranova as SVP, General Counsel and Secretary
Jose Ibietatorremendia to join Veranova as SVP, General Counsel and Secretary
Veranova announces the appointment of Jose Ibietatorremendia as the company’s SVP, General Counsel and Secretary, reporting to Chief Executive Officer, Mike Riley
Transgene strengthens its leadership team to accelerate its growth strategy
Transgene strengthens its leadership team to accelerate its growth strategy
Transgene is pleased to announce the appointment of Arnaud Dubarry as Chief Financial Officer (CFO), effective 1 January 2024